Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Diagnosis and Tracking of Past SARS-CoV-2 Infection in a Large Study of Vo’, Italy Through T-Cell Receptor Sequencing

View ORCID ProfileRachel M. Gittelman, Enrico Lavezzo, View ORCID ProfileThomas M. Snyder, H. Jabran Zahid, Rebecca Elyanow, Sudeb Dalai, Ilan Kirsch, Lance Baldo, Laura Manuto, Elisa Franchin, Claudia Del Vecchio, Fabio Simeoni, Jessica Bordini, Nicola I. Lorè, Dejan Lazarevic, Daniela M. Cirillo, Paolo Ghia, Stefano Toppo, Jonathan M. Carlson, Harlan S. Robins, Giovanni Tonon, Andrea Crisanti
doi: https://doi.org/10.1101/2020.11.09.20228023
Rachel M. Gittelman
1Adaptive Biotechnologies, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rachel M. Gittelman
Enrico Lavezzo
2Department of Molecular Medicine, University of Padova, Padua, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas M. Snyder
1Adaptive Biotechnologies, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas M. Snyder
H. Jabran Zahid
3Microsoft Research, Redmond, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Elyanow
1Adaptive Biotechnologies, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudeb Dalai
1Adaptive Biotechnologies, Seattle, WA, USA
4Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilan Kirsch
1Adaptive Biotechnologies, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lance Baldo
1Adaptive Biotechnologies, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Manuto
2Department of Molecular Medicine, University of Padova, Padua, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Franchin
2Department of Molecular Medicine, University of Padova, Padua, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Del Vecchio
2Department of Molecular Medicine, University of Padova, Padua, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabio Simeoni
5Center for Omics Sciences, IRCCS Ospedale San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Bordini
6Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola I. Lorè
7Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dejan Lazarevic
5Center for Omics Sciences, IRCCS Ospedale San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela M. Cirillo
7Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Ghia
6Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy
8Università Vita-Salute San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Toppo
2Department of Molecular Medicine, University of Padova, Padua, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan M. Carlson
3Microsoft Research, Redmond, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harlan S. Robins
1Adaptive Biotechnologies, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hrobins@adaptivebiotech.com tonon.giovanni@hsr.it andrea.crisanti@unipd.it
Giovanni Tonon
5Center for Omics Sciences, IRCCS Ospedale San Raffaele, Milan, Italy
7Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hrobins@adaptivebiotech.com tonon.giovanni@hsr.it andrea.crisanti@unipd.it
Andrea Crisanti
2Department of Molecular Medicine, University of Padova, Padua, Italy
9Department of Life Sciences, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hrobins@adaptivebiotech.com tonon.giovanni@hsr.it andrea.crisanti@unipd.it
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Measuring the adaptive immune response after SARS-CoV-2 infection may improve our understanding of COVID-19 exposure and potential future protection or immunity. We analyzed T-cell and antibody signatures in a large population study of over 2,200 individuals from the municipality of Vo’, Italy, including 70 PCR-confirmed SARS-CoV-2 cases (24 asymptomatic, 37 symptomatic, 9 hospitalized). Blood samples taken 60 days after PCR diagnosis demonstrated 97% (68/70) of the latter subjects had a positive T-cell test result, higher than an antibody serology assay (77%; 54/70 of subjects) performed on the same samples. The depth and breadth of the T-cell response was associated with disease severity, with symptomatic and hospitalized COVID-19 cases having significantly higher response than asymptomatic cases. In contrast, antibody levels at this convalescent time point were less informative as they did not correlate with disease severity. 45 additional suspected infections were identified based on T-cell response from the 2,220 subjects without confirmatory PCR tests. Among these, notably, subjects who reported symptoms or had household exposure to a PCR-confirmed infection demonstrated a higher T-cell test positive rate. Taken together, these results establish that T cells are a sensitive, reliable and persistent measure of past SARS-CoV-2 infection.

Competing Interest Statement

RM Gittelman, TM Snyder, R Elyanow, S Dalai, I Kirsch, L Baldo have employment and equity ownership with Adaptive Biotechnologies. HS Robins has employment, equity ownership, patents, and royalties with Adaptive Biotechnologies. HJ Zahid and JM Carlson have employment and equity ownership with Microsoft.

Funding Statement

This work was supported by the Veneto region and was jointly funded by the UK Medical Research Council (MRC; grant MR/R015600/1), the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, the Abdul Latif Jameel Foundation and is also part of the EDCTP2 programme supported by the European Union. Support was also provided by the Fondazione Umberto Veronesi, Misura Ricerca Covid 19, year 2020.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The first sampling of the Vo' population was conducted within the surveillance programme established by the Veneto region and did not require ethical approval; the remaining sampling was approved by the Ethics Committee for Clinical Research of the province of Padua. Study participation was by consent. For participants under 18 years of age, consent was provided by a parent or legal guardian.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Clinical data for this cohort (as described in Lavezzo 2020) is available at https://github.com/ncov-ic/SEIR_Covid_Vo. T-cell repertoire profiles are available as part of the ImmuneCODE data resource (Nolan 2020), and can be downloaded from the Adaptive Biotechnologies immuneACCESS site under the immuneACCESS Terms of Use at https://clients.adaptivebiotech.com/pub/covid-2020.

https://github.com/ncov-ic/SEIR_Covid_Vo

https://clients.adaptivebiotech.com/pub/covid-2020

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 12, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Diagnosis and Tracking of Past SARS-CoV-2 Infection in a Large Study of Vo’, Italy Through T-Cell Receptor Sequencing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Diagnosis and Tracking of Past SARS-CoV-2 Infection in a Large Study of Vo’, Italy Through T-Cell Receptor Sequencing
Rachel M. Gittelman, Enrico Lavezzo, Thomas M. Snyder, H. Jabran Zahid, Rebecca Elyanow, Sudeb Dalai, Ilan Kirsch, Lance Baldo, Laura Manuto, Elisa Franchin, Claudia Del Vecchio, Fabio Simeoni, Jessica Bordini, Nicola I. Lorè, Dejan Lazarevic, Daniela M. Cirillo, Paolo Ghia, Stefano Toppo, Jonathan M. Carlson, Harlan S. Robins, Giovanni Tonon, Andrea Crisanti
medRxiv 2020.11.09.20228023; doi: https://doi.org/10.1101/2020.11.09.20228023
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Diagnosis and Tracking of Past SARS-CoV-2 Infection in a Large Study of Vo’, Italy Through T-Cell Receptor Sequencing
Rachel M. Gittelman, Enrico Lavezzo, Thomas M. Snyder, H. Jabran Zahid, Rebecca Elyanow, Sudeb Dalai, Ilan Kirsch, Lance Baldo, Laura Manuto, Elisa Franchin, Claudia Del Vecchio, Fabio Simeoni, Jessica Bordini, Nicola I. Lorè, Dejan Lazarevic, Daniela M. Cirillo, Paolo Ghia, Stefano Toppo, Jonathan M. Carlson, Harlan S. Robins, Giovanni Tonon, Andrea Crisanti
medRxiv 2020.11.09.20228023; doi: https://doi.org/10.1101/2020.11.09.20228023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (433)
  • Anesthesia (99)
  • Cardiovascular Medicine (946)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (420)
  • Epidemiology (8978)
  • Forensic Medicine (4)
  • Gastroenterology (419)
  • Genetic and Genomic Medicine (1947)
  • Geriatric Medicine (190)
  • Health Economics (401)
  • Health Informatics (1327)
  • Health Policy (657)
  • Health Systems and Quality Improvement (519)
  • Hematology (212)
  • HIV/AIDS (419)
  • Infectious Diseases (except HIV/AIDS) (10793)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1824)
  • Nursing (109)
  • Nutrition (272)
  • Obstetrics and Gynecology (352)
  • Occupational and Environmental Health (470)
  • Oncology (997)
  • Ophthalmology (297)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (579)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1895)
  • Public and Global Health (4118)
  • Radiology and Imaging (675)
  • Rehabilitation Medicine and Physical Therapy (366)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (80)